To identify an immortalized cell type in which to study IFN-independent antiviral responses, we screened a number of candidates from the NCI-60 panel of human tumor cell lines for their ability to mount an antiviral response following infection with ultraviolet (UV)-inactivated RNA or DNA viruses. This evidence concerns the gene IFNA1 and neoplasm.